Differences in clinical manifestation of Streptococcus pneumoniae infection are not correlated with in vitro production and release of the virulence factors pneumolysin and lipoteichoic and teichoic acids

Journal of Clinical Microbiology

Volumn 42, Issue 7, 2004, Pages 3342-3345

  Spreer, Annette ^a   Lis, Astrid ^a   Gerber, Joachim ^a   Reinert, Ralf René ^b   Eiffert, Helmut ^a   Nau, Roland ^a,c  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^c UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOTEICHOIC ACID; PNEUMOLYSIN; TEICHOIC ACID; VIRULENCE FACTOR;

ARTICLE; BACTERIUM ISOLATE; CLINICAL FEATURE; DISEASE COURSE; HUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; STRAIN DIFFERENCE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE;

BACTERIAL PROTEINS; HUMANS; LIPOPOLYSACCHARIDES; PNEUMOCOCCAL INFECTIONS; STREPTOLYSINS; TEICHOIC ACIDS;

BACTERIA (MICROORGANISMS); POSIBACTERIA; STREPTOCOCCUS; STREPTOCOCCUS PNEUMONIAE;

EID: 3142742347     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.42.7.3342-3345.2004     Document Type: Article

References (21)

1. Balachandran, P., S. K. Hollingshead, J. C. Paton, and D. E. Briles. 2001. The autolytic enzyme LytA of Streptococcus pneumoniae is not responsible for releasing pneumolysin. J. Bacteriol. 183:3108-3116.
2. Benton, K., J. Paton, and D. Briles. 1997. Differences in virulence for mice among Streptococcus pneumoniae strains of capsular types 2, 3, 4, 5, and 6 are not attributable to differences in pneumolysin production. Infect. Immun. 65:1237-1244.
3. 2 mediate brain cell apoptosis during meningitis. J. Clin. Investig. 109:19-27.
4. Burman, L. A., R. Norrby, and B. Trollfors. 1985. Invasive pneumococcal infections: incidence, predisposing factors, and prognosis. Rev. Infect. Dis. 7:133-142.
5. Cima-Cabal, M. D., F. J. Mendez, F. Vazquez, M. del Mar Garcia-Suarez, and J. R. de los Toyos. 2001. A specific and ultrasensitive chemiluminescent sandwich ELISA test for the detection and quantitation of pneumolysin. J. Immunoass. Immunochem. 22:99-112.
6. Cockeran, R., R. Anderson, and C. Feldman. 2002. The role of pneumolysin in the pathogenesis of Streptococcus pneumoniae infection. Curr. Opin. Infect. Dis. 15:235-239.
7. Dale, J. B., R. W. Baird, H. S. Courtney, D. L. Hasty, and M. S. Bronze. 1994. Passive protection of mice against group A streptococcal pharyngeal infection by lipoteichoic acid. J. Infect. Dis. 169:319-323.
8. Feldman, C., R. Anderson, R. Cockeran, T. Mitchell, P. Cole, and R. Wilson. 2002. The effects of pneumolysin and hydrogen peroxide, alone and in combination, on human ciliated epithelium in vitro. Respir. Med. 96:580-585.
9. French, N., and C. Gilks. 2003. Pneumococcal disease, p. 263-979. In G. C. Cook and A. Zumla (ed.), Manson's tropical diseases, 21st ed. Saunders, Philadelphia, Pa.
10. Ginsburg, I. 2002. Role of lipoteichoic acid in infection and inflammation. Lancet Infect. Dis. 2:171-179.
11. Hakenbeck, R., N. Balmelle, B. Weber, C. Gardes, W. Keck, and A. de Saizieu. 2001. Mosaic genes and mosaic chromosomes: intra- and interspecies genomic variation of Streptococcus pneumoniae. Infect. Immun. 69:2477-2486.
12. Hirst, R. A., K. S. Sikand, A. Rutman, T. J. Mitchell, P. W. Andrew, and C. O'Callaghan. 2000. Relative roles of pneumolysin and hydrogen peroxide from Streptococcus pneumoniae in inhibition of ependymal ciliary beat frequency. Infect. Immun. 68:1557-1562.
13. Jedrzejas, M. J. 2001. Pneumococcal virulence factors: structure and function. Microbiol. Mol. Biol. Rev. 65:187-207.
14. Johnson, M. K. 1977. Cellular location of pneumolysin. FEMS Microbiol. Lett. 2:243-245.
15. Kanclerski, K., and R. Mollby. 1987. Production and purification of Streptococcus pneumoniae hemolysin (pneumolysin). J. Clin. Microbiol. 25:222-225.
16. Musher, D. M. 2000. Streptococcus pneumoniae, p. 2128-2147. In G. L. Mandell, J. E. Bennett, and R. Dolin (ed.), Principles and practice of infectious diseases, vol. 2. Churchill Livingstone, Philadelphia, Pa.
17. Rubins, J., D. Charboneau, J. Paton, T. Mitchell, P. Andrew, and E. Janoff. 1995. Dual function of pneumolysin in the early pathogenesis of murine pneumococcal pneumonia. J. Clin. Investig. 95:142-150.
18. Spreer, A., H. Kerstan, T. Bottcher, J. Gerber, A. Siemer, G. Zysk, T. J. Mitchell, H. Eiffert, and R. Nau. 2003. Reduced release of pneumolysin by Streptococcus pneumoniae in vitro and in vivo after treatment with nonbacteriolytic antibiotics in comparison to ceftriaxone. Antimicrob. Agents Chemother. 47:2649-2654.
19. Stringaris, A. K., J. Geisenhainer, F. Bergmann, C. Balshusemann, U. Lee, G. Zysk, T. J. Mitchell, B. U. Keller, U. Kuhnt, J. Gerber, A. Spreer, M. Bahr, U. Michel, and R. Nau. 2002. Neurotoxicity of pneumolysin, a major pneumococcal virulence factor, involves calcium influx and depends on activation of p38 mitogen-activated protein kinase. Neurobiol. Dis. 11:355-368.
20. Stuertz, K., H. Schmidt, H. Eiffert, P. Schwartz, M. Mäder, and R. Nau. 1998. Differential release of lipoteichoic and teichoic acids from Streptococcus pneumoniae as a result of exposure to β-lactam antibiotics, rifamycins, trovafloxacin, and quinupristin-dalfopristin. Antimicrob. Agents Chemother. 42:277-281.
21. Walker, J., R. Allen, P. Falmagne, M. Johnson, and G. Boulnois. 1987. Molecular cloning, characterization, and complete nucleotide sequence of the gene for pneumolysin, the sulfhydryl-activated toxin of Streptococcus pneumoniae. Infect. Immun. 55:1184-1189.